Physician profile
Patrick P Daily
NPI 1487686374
$12,191.14
in general payments reported to CMS, 2019-2025
43 companies · $1,737 in 2025
The $1,737 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,170 · 2020: $601 · 2021: $961 · 2022: $2,611 · 2023: $2,520 · 2024: $1,591 · 2025: $1,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,304 · Travel and Lodging: $350 · Education: $171 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,304.03 |
| Travel and Lodging | $350.27 |
| Education | $170.84 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,839.78 | 2019-2024 | Da Vinci Surgical System |
| Janssen Biotech, INC. | $2,282.45 | 2019-2025 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $992.99 | 2019-2025 | Provenge |
| Pfizer INC. | $642.36 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $612.88 | 2021-2024 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $563.97 | 2019-2025 | |
| Astellas Pharma US INC | $487.27 | 2019-2025 | Xtandi, Myrbetriq |
| Teleflex LLC | $484.63 | 2022-2024 | Urolift |
| Abbvie INC. | $474.34 | 2019-2024 | Botox, Lupron Depot |
| Amgen INC. | $227.94 | 2019-2024 | Prolia |
| Sumitomo Pharma America, INC. | $223.49 | 2023-2025 | Gemtesa, Orgovyx |
| Neotract INC. | $222.21 | 2019-2020 | |
| Allergan, INC. | $201.32 | 2019-2021 | |
| Accord Healthcare, INC. | $188.48 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $161.08 | 2021-2025 | Keytruda, Lynparza |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $128.57 | 2023-2024 | Trelstar |
| Astrazeneca Pharmaceuticals Lp | $119.69 | 2025 | Lynparza |
| Coloplast Corp | $118.53 | 2019-2024 | |
| Tolmar, INC. | $112.18 | 2023-2025 | Eligard, Rubraca |
| Endo Pharmaceuticals INC. | $105.99 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $91.89 | 2020 | |
| Progenics Pharmaceuticals, INC. | $89.64 | 2021-2024 | Pylarify |
| Davol INC. | $87.67 | 2019 | |
| Ferring Pharmaceuticals INC. | $83.08 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $82.03 | 2021-2025 | |
| Olympus America INC. | $76.70 | 2020-2025 | Itind System |
| Novartis Pharmaceuticals Corporation | $72.98 | 2023-2025 | |
| Boston Scientific Corporation | $59.13 | 2019-2023 | Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $54.27 | 2022-2025 | Aquabeam Robotic System |
| Steris Corporation | $40.87 | 2024 | |
| Medtronic, INC. | $30.70 | 2024-2025 | Interstim, Plasmablade(Tm) |
| Blue Earth Diagnostics | $29.72 | 2021-2025 | Posluma |
| Travere Therapeutics, INC. | $27.94 | 2022-2025 | Thiola |
| Mission Pharmacal Company | $27.45 | 2020-2022 | |
| Pharmaand Gmbh | $25.39 | 2025 | Rubraca |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Civco Medical Instruments | $18.46 | 2025 | |
| Cycle Pharmaceuticals INC | $16.94 | 2025 | Venxxiva |
| Rochester Medical Corporation | $15.42 | 2019 | |
| Angiodynamics, INC. | $13.81 | 2024 | Nanoknife |
| Acerus Pharmaceuticals Corporation | $12.62 | 2021 | |
| Urovant Sciences INC | $11.81 | 2022 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Daily listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.